Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 11 de 11
1.
Nat Commun ; 3: 1030, 2012.
Article En | MEDLINE | ID: mdl-22929787

Direct visualization of axonal transport in live neurons is essential for our understanding of the neuronal functions and the working mechanisms of microtubule-based motor proteins. Here we use the high-speed single particle orientation and rotational tracking technique to directly visualize the rotational dynamics of cargos in both active directional transport and pausing stages of axonal transport, with a temporal resolution of 2 ms. Both long and short pauses are imaged, and the correlations between the pause duration, the rotational behaviour of the cargo at the pause, and the moving direction after the pause are established. Furthermore, the rotational dynamics leading to switching tracks are visualized in detail. These first-time observations of cargo's rotational dynamics provide new insights on how kinesin and dynein motors take the cargo through the alternating stages of active directional transport and pause.


Axonal Transport , Axons/metabolism , Animals , Axons/chemistry , Biological Transport, Active , Dyneins/metabolism , Endocytosis , Kinesins/metabolism , PC12 Cells , Rats , Rotation
2.
BMC Complement Altern Med ; 10: 72, 2010 Nov 23.
Article En | MEDLINE | ID: mdl-21092239

BACKGROUND: With a traditional medical use for treatment of various ailments, herbal preparations of Echinacea are now popularly used to improve immune responses. One likely mode of action is that alkamides from Echinacea bind to cannabinoid type 2 (CB2) receptors and induce a transient increase in intracellular Ca2+. Here, we show that unidentified compounds from Echinacea purpurea induce cytosolic Ca2+ elevation in non-immune-related cells, which lack CB2 receptors and that the Ca2+ elevation is not influenced by alkamides. METHODS: A non-immune human cell line, HEK293, was chosen to evaluate E. purpurea root extracts and constituents as potential regulators of intracellular Ca2+ levels. Changes in cytosolic Ca2+ levels were monitored and visualized by intracellular calcium imaging. U73122, a phospholipase C inhibitor, and 2-aminoethoxydiphenyl borate (2-APB), an antagonist of inositol-1,4,5-trisphosphate (IP3) receptor, were tested to determine the mechanism of this Ca2+ signaling pathway. E. purpurea root ethanol extracts were fractionated by preparative HPLC, screened for bioactivity on HEK293 cells and by GC-MS for potential constituent(s) responsible for this bioactivity. RESULTS: A rapid transient increase in cytosolic Ca2+ levels occurs when E. purpurea extracts are applied to HEK293 cells. These stimulatory effects are phospholipase C and IP3 receptor dependent. Echinacea-evoked responses could not be blocked by SR 144528, a specific CB2 receptor antagonist, indicating that CB2 is not involved. Ca2+ elevation is sustained after the Echinacea-induced Ca2+ release from intracellular Ca2+ stores; this longer-term effect is abolished by 2-APB, indicating a possible store operated calcium entry involvement. Of 28 HPLC fractions from E. purpurea root extracts, six induce cytosolic Ca2+ increase. Interestingly, GC-MS analysis of these fractions, as well as treatment of HEK293 cells with known individual and combined chemicals, indicates the components thought to be responsible for the major immunomodulatory bioactivity of Echinacea do not explain the observed Ca2+ response. Rather, lipophilic constituents of unknown structures are associated with this bioactivity. CONCLUSIONS: Our data indicate that as yet unidentified constituents from Echinacea stimulate an IP3 receptor and phospholipase C mediation of cytosolic Ca2+ levels in non-immune mammalian cells. This pathway is distinct from that induced in immune associated cells via the CB2 receptor.


Calcium/metabolism , Cytosol/drug effects , Echinacea/chemistry , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Plant Extracts/pharmacology , Type C Phospholipases/metabolism , Boron Compounds/pharmacology , Camphanes/pharmacology , Cations/metabolism , Chromatography, High Pressure Liquid , Cytosol/metabolism , Gas Chromatography-Mass Spectrometry , HEK293 Cells , Humans , Plant Roots , Pyrazoles/pharmacology , Receptor, Cannabinoid, CB2/metabolism , Signal Transduction/drug effects
3.
J Cell Mol Med ; 13(2): 365-72, 2009 Feb.
Article En | MEDLINE | ID: mdl-18400049

Secretion is a universal cellular process occurring in bakers yeast, to the complex multicellular organisms, to humans beings. Neurotransmission, digestion, immune response or the release of hormones occur as a result of cell secretion. Secretory defects result in numerous diseases and hence a molecular understanding of the process is critical. Cell secretion involves the transport of vesicular products from within cells to the outside. Porosomes are permanent cup-shaped supramolecular structures at the cell plasma membrane, where secretory vesicles transiently dock and transiently fuse to release intravesicular contents to the outside. In the past decade, porosomes have been determined to be the universal secretory machinery in cells, present in the exocrine pancreas, endocrine and neuroendocrine cells, and in neurons. In this study, we report for the first time the presence of porosomes in rat brain astrocytes. Using atomic force microscopy on live astrocytes, cup-shaped porosomes measuring 10-15 nm are observed at the cell plasma membrane. Further studies using electron microscopy confirm the presence of porosomes in astrocytes. Analogous to neuronal porosomes, there is a central plug in the astrocyte porosome complex. Immunoisolation and reconstitution of the astrocyte porosome in lipid membrane, demonstrates a structure similar to what is observed in live cells. These studies demonstrate that in astrocytes, the secretory apparatus at the cell plasma membrane is similar to what is found in neurons.


Astrocytes , Cell Membrane , Exocytosis/physiology , Animals , Astrocytes/cytology , Astrocytes/metabolism , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Cells, Cultured , Humans , Microscopy, Atomic Force , Neurons/cytology , Neurons/metabolism , Rats , Secretory Vesicles/metabolism , Synaptosomal-Associated Protein 25/metabolism , Vesicular Transport Proteins/metabolism
4.
Cell Biol Int ; 33(2): 224-9, 2009 Feb.
Article En | MEDLINE | ID: mdl-19084606

The astrocyte porosome complex, the secretory machinery at the plasma membrane of astrocytes, is a 10-15 nm cup-shaped lipoprotein structure possessing a central plug. Since the porosome is a membrane-associated, multi-protein complex, it has precluded the generation of 3D crystals for X-ray diffraction studies, nor structural analysis at the atomic level using the solution NMR. These limitations were partially overcome in the current studies, furthering our understanding of the porosome structure in astrocytes. Using atomic force microscopy, electron microscopy, and electron density and 3D contour mapping, finally provides at the nanoscale, the structure and assembly of proteins within the astrocyte porosome complex. Results from this study demonstrate a set of protein units lining the porosome cup, each connected via spoke-like elements to a central plug region within the structure. In contrast to the neuronal porosome, which possess eight globular proteins at the outer rim of the complex, the porosome complex appear to possess 12 such globular structures. Nature has designed the porosome as the universal secretory machinery, but has fine-tuned its use to suite secretion from different cell types. The isolation of intact astrocyte porosomes for near-atomic resolution using cryo-electron diffraction measurements, is finally possible.


Astrocytes/ultrastructure , Imaging, Three-Dimensional , Proteins/ultrastructure , Animals , Electron Microscope Tomography , Microscopy, Atomic Force , Nanotechnology , Proteins/chemistry , Rats
5.
Stem Cells ; 23(8): 1044-9, 2005 Sep.
Article En | MEDLINE | ID: mdl-15955833

In order for stem cells to fulfill their clinical promise, we must understand their developmental transitions and it must be possible to control the differentiation of stem cells into specific cell fates. To understand the mechanism of the sequential restriction and multipotency of stem cells, we have established culture conditions that allow the differentiation of multipotential neural stem cells from postnatal stem cells. We used immunocytochemistry, fluorescence microscopy, and calcium imaging to demonstrate that progeny of adult rat neural stem cells develop into functional neurons that release excitatory neurotransmitters. We also found that the nontoxic heavy chain fragment of tetanus toxin, a toxin that targets neurons with high specificity, retained the specificity toward neural stem cell-derived neurons. These studies show that neural stem cells derived from adult tissues retain the potential to differentiate into functional neurons with morphological and functional properties of mature central nervous system neurons.


Cell Differentiation , Neurons/cytology , Stem Cells/cytology , Adenosine Triphosphate/pharmacology , Animals , Calcium/metabolism , Calcium Channels/metabolism , Cells, Cultured , Culture Media/chemistry , Glutamic Acid/metabolism , Immunohistochemistry , Microscopy, Confocal , Microtubule-Associated Proteins/analysis , Neurons/drug effects , Neurons/metabolism , Optic Nerve , Peptide Fragments/pharmacology , Potassium/metabolism , Rats , Rats, Sprague-Dawley , Receptors, AMPA/metabolism , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2X , Stem Cells/drug effects , Stem Cells/metabolism , Tetanus Toxin/pharmacology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology
6.
Neuroendocrinology ; 80(2): 73-82, 2004.
Article En | MEDLINE | ID: mdl-15528950

Leptin, the product of the obese gene, is a protein that is secreted primarily from adipocytes. Leptin can influence the function of the pituitary gland through its action on the hypothalamus, but it can also directly act at the level of the pituitary gland. The ability of leptin to induce an increase in intracellular Ca2+ concentration ([Ca2+]i) in somatotropes was examined in dispersed porcine pituitary cells using a calcium imaging system. Somatotropes were functionally identified by the application of human growth hormone releasing hormone. Leptin increased [Ca2+]i in porcine somatotropes in a dose-dependent manner. The application of 100 nM leptin for 3 min did not have a significant effect on [Ca2+]i, while a 3-min application of 1 microM leptin increased [Ca2+]i in about 50% of the somatotropes (p < 0.01). The application of a second leptin challenge (1 microM) evoked a response in only 18% of the observed somatotropes. The stimulatory effect of leptin was abolished in low calcium saline and blocked by nifedipine, an L-calcium channel blocker, suggesting an involvement of calcium channels. Pretreatment of the cultures with AG 490, a specific Janus kinase inhibitor, and with SB 203580, a mitogen-activated protein kinase (MAP kinase) inhibitor, abolished the increase in [Ca2+]i evoked by leptin. In the presence of N(omega)-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase (NOS) inhibitor, the magnitude of the increase in [Ca2+]i evoked by 1 microM leptin was not significantly changed. However, in the presence of L-NAME only 24% of the somatotropes responded to leptin, while in parallel control cultures 70% of the somatotropes responded to leptin. These results imply an involvement of Janus kinase/signal transducer and activator or transcription, MAP kinase and NOS-signaling pathways in the stimulatory effect of leptin on porcine somatotropes.


Calcium/metabolism , Leptin/pharmacology , Pituitary Gland, Anterior/cytology , Pituitary Gland, Anterior/drug effects , Signal Transduction/physiology , Animals , Animals, Newborn , Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Calcium Channels/metabolism , Cells, Cultured , DNA-Binding Proteins/drug effects , DNA-Binding Proteins/metabolism , In Vitro Techniques , Intracellular Fluid/chemistry , Mitogen-Activated Protein Kinases/drug effects , Mitogen-Activated Protein Kinases/metabolism , Nifedipine/pharmacology , Nitric Oxide Synthase/drug effects , Nitric Oxide Synthase/metabolism , Protein-Tyrosine Kinases/drug effects , Protein-Tyrosine Kinases/metabolism , Signal Transduction/drug effects , Swine , Trans-Activators/drug effects , Trans-Activators/metabolism
7.
Histochem Cell Biol ; 122(6): 571-7, 2004 Dec.
Article En | MEDLINE | ID: mdl-15490218

The objective of this immunohistochemical study was to identify the spatial distribution patterns of growth hormone (GH) secreting cells (somatotrophs) in the newborn and prepubertal porcine pituitary. No differences were observed among the total somatotrophs per unit area across the three ages. There were, however, changes in spatial distribution of somatotrophs in porcine pituitary with developmental age. Distinctive characteristics of the pattern included a high population of somatotrophs (44 +/- 1.2; mean +/- standard error of the mean per 30,495 microm(2)) in regions 1 and 5 and a low population (22 +/- 1.4) in regions 2 and 4 at each level (P < 0.05). Somatotrophs increased 55% in region 3 from proximal to distal levels at all ages. With increasing age, however, somatotrophs in region 3 at the proximal level decreased 33%. From these results, we suggest that there may be regional specificity of cellular differentiation and transformation to facilitate GH secretion to meet the need for endocrine regulation as the animal ages.


Growth Hormone/metabolism , Pituitary Gland, Anterior/cytology , Aging , Animals , Animals, Newborn , Immunohistochemistry/methods , Pituitary Gland, Anterior/growth & development , Pituitary Gland, Anterior/metabolism , Swine
8.
J Am Chem Soc ; 126(41): 13216-7, 2004 Oct 20.
Article En | MEDLINE | ID: mdl-15479063

We synthesized a MCM-41-type mesoporous silica nanosphere (MSN)-based gene transfection system, where second generation (G2) polyamidoamines (PAMAMs) were covalently attached to the surface of MSN. The G2-PAMAM-capped MSN material (G2-MSN) was used to complex with a plasmid DNA (pEGFP-C1) that encodes for an enhanced green fluorescence protein. The gene transfection efficacy, uptake mechanism, and biocompatibility of the G2-MSN system with various cell types, such as neural glia (astrocytes), human cervical cancer (HeLa), and Chinese hamster ovarian (CHO) cells, were investigated. The mesoporous structure of the MSN material allows membrane-impermeable molecules, such as pharmaceutical drugs and fluorescent dyes, to be encapsulated inside the MSN channels. The system renders the possibility to serve as a universal transmembrane carrier for intracellular drug delivery and imaging applications.


DNA/administration & dosage , Nanostructures/chemistry , Plasmids/administration & dosage , Polyamines/administration & dosage , Silicon Dioxide/chemistry , Transfection/methods , Animals , Astrocytes/metabolism , Astrocytes/physiology , Biocompatible Materials/administration & dosage , Biocompatible Materials/chemistry , CHO Cells , Cricetinae , DNA/chemistry , Dendrimers , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , HeLa Cells , Humans , Microscopy, Fluorescence , Models, Molecular , Plasmids/chemistry , Polyamines/chemistry , Rats
9.
Neuroendocrinology ; 77(6): 367-79, 2003 Jun.
Article En | MEDLINE | ID: mdl-12845223

Research on the mechanism for growth hormone secretagogue (GHS) induction of growth hormone secretion led to the discovery of the GHS receptor (GHS-R) and later to ghrelin, an endogenous ligand for GHS-R. The ability of ghrelin to induce an increase in the intracellular Ca(2+) concentration - [Ca(2+)](i) - in somatotropes was examined in dispersed porcine pituitary cells using a calcium imaging system. Somatotropes were functionally identified by application of human growth hormone releasing hormone. Ghrelin increased the [Ca(2+)](i) in a dose-dependent manner in 98% of the cells that responded to human growth hormone releasing hormone. In the presence of (D-Lys(3))-GHRP-6, a specific receptor antagonist of GHS-R, the increase in [Ca(2+)](i) evoked by ghrelin was decreased. Pretreatment of cultures with somatostatin or neuropeptide Y reduced the ghrelin-induced increase of [Ca(2+)](i). The stimulatory effect of ghrelin on somatotropes was greatly attenuated in low-calcium saline and blocked by nifedipine, an L-type calcium channel blocker, suggesting involvement of calcium channels. In a zero Na(+) solution, the stimulatory effect of ghrelin on somatotropes was decreased, suggesting that besides calcium channels, sodium channels are also involved in ghrelin-induced calcium transients. Either SQ-22536, an adenylyl cyclase inhibitor, or U73122, a phospholipase C inhibitor, decreased the stimulatory effects of ghrelin on [Ca(2+)](i) transiently, indicating the involvement of adenylyl cyclase-cyclic adenosine monophosphate and phospholipase C inositol 1,4,5-trisphosphate pathways. The nonpeptidyl GHS, L-692,585 (L-585), induced changes in [Ca(2+)](i) similar to those observed with ghrelin. Application of L-585 after ghrelin did not have additive effects on [Ca(2+)](i). Preapplication of L-585 blocked the stimulatory effect of ghrelin on somatotropes. Simultaneous application of ghrelin and L-585 did not cause an additive increase in [Ca(2+)](i). Our results suggest that the actions of ghrelin and synthetic GHS closely parallel each other, in a manner that is consistent with an increase of hormone secretion.


Benzazepines/pharmacology , Calcium/metabolism , Growth Hormone-Releasing Hormone/metabolism , Growth Hormone/metabolism , Peptide Hormones/metabolism , Pituitary Gland/metabolism , Receptors, G-Protein-Coupled , Signal Transduction/drug effects , Tetrazoles/pharmacology , Adenylyl Cyclase Inhibitors , Animals , Animals, Newborn , Benzazepines/metabolism , Calcium Channels, L-Type/metabolism , Cell Culture Techniques , Dose-Response Relationship, Drug , Ghrelin , Growth Hormone/drug effects , Growth Hormone-Releasing Hormone/administration & dosage , Immunohistochemistry , Neuropeptide Y/metabolism , Neuropeptide Y/pharmacology , Nifedipine/pharmacology , Peptide Hormones/administration & dosage , Pituitary Gland/drug effects , Receptors, Cell Surface/antagonists & inhibitors , Receptors, Ghrelin , Sodium Channels/metabolism , Somatostatin/metabolism , Somatostatin/pharmacology , Swine , Tetrazoles/metabolism , Type C Phospholipases/antagonists & inhibitors
10.
J Am Chem Soc ; 125(15): 4451-9, 2003 Apr 16.
Article En | MEDLINE | ID: mdl-12683815

An MCM-41 type mesoporous silica nanosphere-based (MSN) controlled-release delivery system has been synthesized and characterized using surface-derivatized cadmium sulfide (CdS) nanocrystals as chemically removable caps to encapsulate several pharmaceutical drug molecules and neurotransmitters inside the organically functionalized MSN mesoporous framework. We studied the stimuli-responsive release profiles of vancomycin- and adenosine triphosphate (ATP)-loaded MSN delivery systems by using disulfide bond-reducing molecules, such as dithiothreitol (DTT) and mercaptoethanol (ME), as release triggers. The biocompatibility and delivery efficiency of the MSN system with neuroglial cells (astrocytes) in vitro were demonstrated. In contrast to many current delivery systems, the molecules of interest were encapsulated inside the porous framework of the MSN not by adsorption or sol-gel types of entrapment but by capping the openings of the mesoporous channels with size-defined CdS nanoparticles to physically block the drugs/neurotransmitters of certain sizes from leaching out. We envision that this new MSN system could play a significant role in developing new generations of site-selective, controlled-release delivery nanodevices.


Adenosine Triphosphate/administration & dosage , Cadmium Compounds/chemistry , Delayed-Action Preparations , Neurotransmitter Agents/administration & dosage , Silicon Dioxide/chemistry , Sulfides/chemistry , Vancomycin/administration & dosage , Adenosine Triphosphate/chemistry , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Biocompatible Materials/administration & dosage , Biocompatible Materials/chemistry , Cadmium Compounds/administration & dosage , Cells, Cultured , Dithiothreitol/administration & dosage , Dithiothreitol/chemistry , Drug Carriers , Mercaptoethanol/administration & dosage , Mercaptoethanol/chemistry , Neurotransmitter Agents/chemistry , Particle Size , Rats , Silicon Dioxide/administration & dosage , Silicon Dioxide/chemical synthesis , Sulfides/administration & dosage , Vancomycin/chemistry
11.
Endocrinology ; 143(3): 1144-8, 2002 Mar.
Article En | MEDLINE | ID: mdl-11861542

Earlier studies in live pancreatic acinar cells identified new cellular structures at the cell plasma membrane called 'pits' and 'depressions', where membrane-bound secretory vesicles dock and fuse to release vesicular contents. In the current study, using atomic force microscopy we identify similar structures at the plasma membrane of GH-secreting cells of the pituitary and implicate their involvement in hormone release. Pits containing 100-200 nm in diameter depressions or fusion pores were identified in resting GH-secreting cells. Following stimulation of secretion the size of depression enlarged and gold-tagged GH antibody were found to bind to the pit structures in the stimulated GH cells. This study documents for the first time the presence of these structures and their involvement in secretions in a neuroendocrine cell.


Growth Hormone/metabolism , Pituitary Gland/metabolism , Pituitary Gland/ultrastructure , Actins/metabolism , Animals , Cell Separation , Hemolytic Plaque Technique , Immunohistochemistry , Microscopy, Atomic Force , Neurosecretory Systems/cytology , Neurosecretory Systems/metabolism , Pituitary Gland/cytology , Swine , Tissue Fixation
...